instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the dosage of drug 'DOXORUBICIN HYDROCHLORIDE'? | Resistant hyponatraemia in a patient with follicular lymphoma and heart failure with reduced ejection fraction: a case report.
Hyponatraemia is a common problem in patients with heart failure. It can be difficult to treat, especially in the presence of the patient's needs for diuresis and manipulation of the renin-angi... | CYCLICAL (CYC? 2) | DrugDosageText | CC BY-NC | 34017937 | 19,444,278 | 2021-05 |
What was the dosage of drug 'VINCRISTINE SULFATE'? | Resistant hyponatraemia in a patient with follicular lymphoma and heart failure with reduced ejection fraction: a case report.
Hyponatraemia is a common problem in patients with heart failure. It can be difficult to treat, especially in the presence of the patient's needs for diuresis and manipulation of the renin-angi... | UNK, CYCLIC (CYCLICAL) | DrugDosageText | CC BY-NC | 34017937 | 19,450,777 | 2021-05 |
What was the outcome of reaction 'Acute kidney injury'? | Resistant hyponatraemia in a patient with follicular lymphoma and heart failure with reduced ejection fraction: a case report.
Hyponatraemia is a common problem in patients with heart failure. It can be difficult to treat, especially in the presence of the patient's needs for diuresis and manipulation of the renin-angi... | Recovering | ReactionOutcome | CC BY-NC | 34017937 | 19,450,777 | 2021-05 |
What was the outcome of reaction 'Cardiac failure'? | Resistant hyponatraemia in a patient with follicular lymphoma and heart failure with reduced ejection fraction: a case report.
Hyponatraemia is a common problem in patients with heart failure. It can be difficult to treat, especially in the presence of the patient's needs for diuresis and manipulation of the renin-angi... | Recovering | ReactionOutcome | CC BY-NC | 34017937 | 19,450,777 | 2021-05 |
What was the outcome of reaction 'Cardiotoxicity'? | Resistant hyponatraemia in a patient with follicular lymphoma and heart failure with reduced ejection fraction: a case report.
Hyponatraemia is a common problem in patients with heart failure. It can be difficult to treat, especially in the presence of the patient's needs for diuresis and manipulation of the renin-angi... | Recovering | ReactionOutcome | CC BY-NC | 34017937 | 19,450,777 | 2021-05 |
What was the outcome of reaction 'Hyponatraemia'? | Resistant hyponatraemia in a patient with follicular lymphoma and heart failure with reduced ejection fraction: a case report.
Hyponatraemia is a common problem in patients with heart failure. It can be difficult to treat, especially in the presence of the patient's needs for diuresis and manipulation of the renin-angi... | Recovered | ReactionOutcome | CC BY-NC | 34017937 | 19,475,945 | 2021-05 |
What was the outcome of reaction 'Hypotension'? | Resistant hyponatraemia in a patient with follicular lymphoma and heart failure with reduced ejection fraction: a case report.
Hyponatraemia is a common problem in patients with heart failure. It can be difficult to treat, especially in the presence of the patient's needs for diuresis and manipulation of the renin-angi... | Recovering | ReactionOutcome | CC BY-NC | 34017937 | 19,450,777 | 2021-05 |
What was the outcome of reaction 'Oedema peripheral'? | Resistant hyponatraemia in a patient with follicular lymphoma and heart failure with reduced ejection fraction: a case report.
Hyponatraemia is a common problem in patients with heart failure. It can be difficult to treat, especially in the presence of the patient's needs for diuresis and manipulation of the renin-angi... | Recovering | ReactionOutcome | CC BY-NC | 34017937 | 19,450,777 | 2021-05 |
What was the outcome of reaction 'Pleural effusion'? | Resistant hyponatraemia in a patient with follicular lymphoma and heart failure with reduced ejection fraction: a case report.
Hyponatraemia is a common problem in patients with heart failure. It can be difficult to treat, especially in the presence of the patient's needs for diuresis and manipulation of the renin-angi... | Recovering | ReactionOutcome | CC BY-NC | 34017937 | 19,450,777 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Outcomes of retained and disengaged pregnant women living with HIV in Uganda.
Loss-to-follow-up among women living with HIV (WLWHIV) may lead to unfavorable outcomes for both mother and exposed infant. This study traced WLWHIV disengaged from care and their infants and compared their outcomes with those retained in car... | EFAVIRENZ, LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34019568 | 20,057,395 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Stillbirth'. | Outcomes of retained and disengaged pregnant women living with HIV in Uganda.
Loss-to-follow-up among women living with HIV (WLWHIV) may lead to unfavorable outcomes for both mother and exposed infant. This study traced WLWHIV disengaged from care and their infants and compared their outcomes with those retained in car... | EFAVIRENZ, LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34019568 | 20,057,395 | 2021 |
What was the outcome of reaction 'Maternal exposure during pregnancy'? | Outcomes of retained and disengaged pregnant women living with HIV in Uganda.
Loss-to-follow-up among women living with HIV (WLWHIV) may lead to unfavorable outcomes for both mother and exposed infant. This study traced WLWHIV disengaged from care and their infants and compared their outcomes with those retained in car... | Recovered | ReactionOutcome | CC BY | 34019568 | 20,057,395 | 2021 |
What was the outcome of reaction 'Stillbirth'? | Outcomes of retained and disengaged pregnant women living with HIV in Uganda.
Loss-to-follow-up among women living with HIV (WLWHIV) may lead to unfavorable outcomes for both mother and exposed infant. This study traced WLWHIV disengaged from care and their infants and compared their outcomes with those retained in car... | Recovered | ReactionOutcome | CC BY | 34019568 | 20,057,395 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Symptomatic sinus bradycardia due to electrolyte imbalances in syndrome of inappropriate antidiuretic hormone (SIADH) related covid-19: a case report.
BACKGROUND
Coronavirus Disease-2019 (COVID-19) has been declared a global pandemic since March 11th, 2020. Despite emerging reports and literature covering a broad spect... | AZITHROMYCIN, OSELTAMIVIR PHOSPHATE | DrugsGivenReaction | CC BY | 34020617 | 20,418,219 | 2021-05-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperglycaemia'. | High-dose vitamin-C induced prolonged factitious hyperglycemia in a peritoneal dialysis patient: a case report.
BACKGROUND
High-dose vitamin C is increasingly used for sepsis and more recently for coronavirus disease 2019 (COVID-19) infections. Proponents argue that the low cost and near perfect safety profile of vitam... | ASCORBIC ACID | DrugsGivenReaction | CC BY | 34020705 | 19,508,564 | 2021-05-21 |
What was the administration route of drug 'ASCORBIC ACID'? | High-dose vitamin-C induced prolonged factitious hyperglycemia in a peritoneal dialysis patient: a case report.
BACKGROUND
High-dose vitamin C is increasingly used for sepsis and more recently for coronavirus disease 2019 (COVID-19) infections. Proponents argue that the low cost and near perfect safety profile of vitam... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34020705 | 19,508,564 | 2021-05-21 |
What was the dosage of drug 'ASCORBIC ACID'? | High-dose vitamin-C induced prolonged factitious hyperglycemia in a peritoneal dialysis patient: a case report.
BACKGROUND
High-dose vitamin C is increasingly used for sepsis and more recently for coronavirus disease 2019 (COVID-19) infections. Proponents argue that the low cost and near perfect safety profile of vitam... | 50 MILLIGRAM/KILOGRAM, Q6H, FOR 96 HOURS | DrugDosageText | CC BY | 34020705 | 19,508,564 | 2021-05-21 |
What was the outcome of reaction 'Hyperglycaemia'? | High-dose vitamin-C induced prolonged factitious hyperglycemia in a peritoneal dialysis patient: a case report.
BACKGROUND
High-dose vitamin C is increasingly used for sepsis and more recently for coronavirus disease 2019 (COVID-19) infections. Proponents argue that the low cost and near perfect safety profile of vitam... | Recovering | ReactionOutcome | CC BY | 34020705 | 19,508,564 | 2021-05-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Recurrent noncirrhotic hyperammonemia causing acute metabolic encephalopathy in a patient with a continent ileocecal pouch: a case report.
BACKGROUND
Acute encephalopathy, while a common presentation in the emergency department, is typically caused by a variety of metabolic, vascular, infectious, structural, or psychia... | DAPTOMYCIN, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM | DrugsGivenReaction | CC BY | 34020707 | 20,127,897 | 2021-05-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Duodenal ulcer perforation'. | Management of severe frostbite with iloprost, alteplase and heparin: a Yukon case series.
We identified the need to modernize frostbite management in our northern centre and implemented a treatment protocol in 2015. Our aim was to describe the clinical course of patients presenting to the hospital since the implementat... | IBUPROFEN, ILOPROST | DrugsGivenReaction | CC BY-NC-ND | 34021017 | 20,007,588 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Management of severe frostbite with iloprost, alteplase and heparin: a Yukon case series.
We identified the need to modernize frostbite management in our northern centre and implemented a treatment protocol in 2015. Our aim was to describe the clinical course of patients presenting to the hospital since the implementat... | IBUPROFEN, ILOPROST | DrugsGivenReaction | CC BY-NC-ND | 34021017 | 20,007,588 | 2021 |
What was the administration route of drug 'IBUPROFEN'? | Management of severe frostbite with iloprost, alteplase and heparin: a Yukon case series.
We identified the need to modernize frostbite management in our northern centre and implemented a treatment protocol in 2015. Our aim was to describe the clinical course of patients presenting to the hospital since the implementat... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34021017 | 20,007,588 | 2021 |
What was the dosage of drug 'IBUPROFEN'? | Management of severe frostbite with iloprost, alteplase and heparin: a Yukon case series.
We identified the need to modernize frostbite management in our northern centre and implemented a treatment protocol in 2015. Our aim was to describe the clinical course of patients presenting to the hospital since the implementat... | 2400 mg (milligrams). | DrugDosage | CC BY-NC-ND | 34021017 | 20,007,588 | 2021 |
What was the outcome of reaction 'Product use in unapproved indication'? | Management of severe frostbite with iloprost, alteplase and heparin: a Yukon case series.
We identified the need to modernize frostbite management in our northern centre and implemented a treatment protocol in 2015. Our aim was to describe the clinical course of patients presenting to the hospital since the implementat... | Recovered with sequelae (consequent health issues) | ReactionOutcome | CC BY-NC-ND | 34021017 | 20,007,588 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug intolerance'. | Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target.
Sarcomas harboring EWSR1-NFATc2 fusions have historically been categorized and treated as Ewing sarcoma. Emerging evidence suggests unique molecular characteristics and chemotherapy sensiti... | CYCLOPHOSPHAMIDE, DACTINOMYCIN, ETOPOSIDE, IFOSFAMIDE, IRINOTECAN, PAZOPANIB, VINCRISTINE | DrugsGivenReaction | CC BY | 34021224 | 19,913,183 | 2021-05-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target.
Sarcomas harboring EWSR1-NFATc2 fusions have historically been categorized and treated as Ewing sarcoma. Emerging evidence suggests unique molecular characteristics and chemotherapy sensiti... | CYCLOPHOSPHAMIDE, DACTINOMYCIN, ETOPOSIDE, IFOSFAMIDE, PAZOPANIB, VINCRISTINE | DrugsGivenReaction | CC BY | 34021224 | 19,895,670 | 2021-05-21 |
What was the dosage of drug 'VINCRISTINE'? | Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target.
Sarcomas harboring EWSR1-NFATc2 fusions have historically been categorized and treated as Ewing sarcoma. Emerging evidence suggests unique molecular characteristics and chemotherapy sensiti... | UNK, 4 CYCLICAL | DrugDosageText | CC BY | 34021224 | 19,913,183 | 2021-05-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Chlormethine Gel for the Treatment of Skin Lesions in All Stages of Mycosis Fungoides Cutaneous T-Cell Lymphoma: A Narrative Review and International Experience.
Mycosis fungoides (MF), the most common form of primary cutaneous T-cell lymphoma, is a disease typically with an indolent course that is initially characteri... | CLOBETASOL | DrugsGivenReaction | CC BY-NC | 34021485 | 20,215,908 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Chlormethine Gel for the Treatment of Skin Lesions in All Stages of Mycosis Fungoides Cutaneous T-Cell Lymphoma: A Narrative Review and International Experience.
Mycosis fungoides (MF), the most common form of primary cutaneous T-cell lymphoma, is a disease typically with an indolent course that is initially characteri... | CLOBETASOL | DrugsGivenReaction | CC BY-NC | 34021485 | 20,215,908 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Chlormethine Gel for the Treatment of Skin Lesions in All Stages of Mycosis Fungoides Cutaneous T-Cell Lymphoma: A Narrative Review and International Experience.
Mycosis fungoides (MF), the most common form of primary cutaneous T-cell lymphoma, is a disease typically with an indolent course that is initially characteri... | CLOBETASOL | DrugsGivenReaction | CC BY-NC | 34021485 | 20,188,987 | 2021-08 |
What was the administration route of drug 'CLOBETASOL'? | Chlormethine Gel for the Treatment of Skin Lesions in All Stages of Mycosis Fungoides Cutaneous T-Cell Lymphoma: A Narrative Review and International Experience.
Mycosis fungoides (MF), the most common form of primary cutaneous T-cell lymphoma, is a disease typically with an indolent course that is initially characteri... | Topical | DrugAdministrationRoute | CC BY-NC | 34021485 | 20,188,987 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Osteomyelitis chronic'. | Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial.
There are no clinical trials involving patients with diffuse large B-cell lymphoma (DLBCL) in sub-Saharan Africa since antiretroviral therapy (ART) for HIV becam... | CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, PREDNISONE, RITUXIMAB, VINCRISTINE SULFATE | DrugsGivenReaction | CC BY-NC-ND | 34022150 | 19,908,294 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal failure'. | Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial.
There are no clinical trials involving patients with diffuse large B-cell lymphoma (DLBCL) in sub-Saharan Africa since antiretroviral therapy (ART) for HIV becam... | CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, PREDNISONE, RITUXIMAB, VINCRISTINE SULFATE | DrugsGivenReaction | CC BY-NC-ND | 34022150 | 19,908,294 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Staphylococcal infection'. | Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial.
There are no clinical trials involving patients with diffuse large B-cell lymphoma (DLBCL) in sub-Saharan Africa since antiretroviral therapy (ART) for HIV becam... | CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, PREDNISONE, RITUXIMAB, VINCRISTINE SULFATE | DrugsGivenReaction | CC BY-NC-ND | 34022150 | 19,908,294 | 2021-07 |
What was the administration route of drug 'CYCLOPHOSPHAMIDE'? | Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial.
There are no clinical trials involving patients with diffuse large B-cell lymphoma (DLBCL) in sub-Saharan Africa since antiretroviral therapy (ART) for HIV becam... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34022150 | 19,908,294 | 2021-07 |
What was the administration route of drug 'DOXORUBICIN HYDROCHLORIDE'? | Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial.
There are no clinical trials involving patients with diffuse large B-cell lymphoma (DLBCL) in sub-Saharan Africa since antiretroviral therapy (ART) for HIV becam... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34022150 | 19,908,294 | 2021-07 |
What was the administration route of drug 'PREDNISONE'? | Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial.
There are no clinical trials involving patients with diffuse large B-cell lymphoma (DLBCL) in sub-Saharan Africa since antiretroviral therapy (ART) for HIV becam... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34022150 | 19,908,294 | 2021-07 |
What was the administration route of drug 'RITUXIMAB'? | Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial.
There are no clinical trials involving patients with diffuse large B-cell lymphoma (DLBCL) in sub-Saharan Africa since antiretroviral therapy (ART) for HIV becam... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34022150 | 19,908,294 | 2021-07 |
What was the administration route of drug 'VINCRISTINE SULFATE'? | Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial.
There are no clinical trials involving patients with diffuse large B-cell lymphoma (DLBCL) in sub-Saharan Africa since antiretroviral therapy (ART) for HIV becam... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34022150 | 19,908,294 | 2021-07 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial.
There are no clinical trials involving patients with diffuse large B-cell lymphoma (DLBCL) in sub-Saharan Africa since antiretroviral therapy (ART) for HIV becam... | 750 MG/M2, CYCLIC | DrugDosageText | CC BY-NC-ND | 34022150 | 19,908,294 | 2021-07 |
What was the dosage of drug 'DOXORUBICIN HYDROCHLORIDE'? | Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial.
There are no clinical trials involving patients with diffuse large B-cell lymphoma (DLBCL) in sub-Saharan Africa since antiretroviral therapy (ART) for HIV becam... | 50 MG/M2, CYCLIC | DrugDosageText | CC BY-NC-ND | 34022150 | 19,908,294 | 2021-07 |
What was the dosage of drug 'PREDNISONE'? | Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial.
There are no clinical trials involving patients with diffuse large B-cell lymphoma (DLBCL) in sub-Saharan Africa since antiretroviral therapy (ART) for HIV becam... | 100 MG, CYCLIC | DrugDosageText | CC BY-NC-ND | 34022150 | 19,908,294 | 2021-07 |
What was the dosage of drug 'RITUXIMAB'? | Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial.
There are no clinical trials involving patients with diffuse large B-cell lymphoma (DLBCL) in sub-Saharan Africa since antiretroviral therapy (ART) for HIV becam... | 375 MG/M2, CYCLIC | DrugDosageText | CC BY-NC-ND | 34022150 | 19,908,294 | 2021-07 |
What was the dosage of drug 'VINCRISTINE SULFATE'? | Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial.
There are no clinical trials involving patients with diffuse large B-cell lymphoma (DLBCL) in sub-Saharan Africa since antiretroviral therapy (ART) for HIV becam... | 1.4 MG/M2 (MAXIMUM 2 MG/M2) | DrugDosageText | CC BY-NC-ND | 34022150 | 19,908,294 | 2021-07 |
What was the outcome of reaction 'Osteomyelitis chronic'? | Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial.
There are no clinical trials involving patients with diffuse large B-cell lymphoma (DLBCL) in sub-Saharan Africa since antiretroviral therapy (ART) for HIV becam... | Fatal | ReactionOutcome | CC BY-NC-ND | 34022150 | 19,908,294 | 2021-07 |
What was the outcome of reaction 'Renal failure'? | Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial.
There are no clinical trials involving patients with diffuse large B-cell lymphoma (DLBCL) in sub-Saharan Africa since antiretroviral therapy (ART) for HIV becam... | Fatal | ReactionOutcome | CC BY-NC-ND | 34022150 | 19,908,294 | 2021-07 |
What was the outcome of reaction 'Staphylococcal infection'? | Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial.
There are no clinical trials involving patients with diffuse large B-cell lymphoma (DLBCL) in sub-Saharan Africa since antiretroviral therapy (ART) for HIV becam... | Fatal | ReactionOutcome | CC BY-NC-ND | 34022150 | 19,908,294 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute lymphocytic leukaemia'. | Genomic trajectory in leukemogenesis of myeloproliferative neoplasms: a case report.
We report a patient with Essential Thrombocythemia (ET), subsequently diagnosed with concurrent myeloid and lymphoid leukemia. Generally, the molecular mechanisms underlying leukemic transformation of Philadelphia-negative myeloprolife... | ASPIRIN, HYDROXYUREA, LENALIDOMIDE, WARFARIN SODIUM | DrugsGivenReaction | CC BY | 34022887 | 19,397,359 | 2021-05-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chloroma'. | Genomic trajectory in leukemogenesis of myeloproliferative neoplasms: a case report.
We report a patient with Essential Thrombocythemia (ET), subsequently diagnosed with concurrent myeloid and lymphoid leukemia. Generally, the molecular mechanisms underlying leukemic transformation of Philadelphia-negative myeloprolife... | ASPIRIN, HYDROXYUREA, LENALIDOMIDE, WARFARIN SODIUM | DrugsGivenReaction | CC BY | 34022887 | 19,397,359 | 2021-05-22 |
What was the administration route of drug 'LENALIDOMIDE'? | Genomic trajectory in leukemogenesis of myeloproliferative neoplasms: a case report.
We report a patient with Essential Thrombocythemia (ET), subsequently diagnosed with concurrent myeloid and lymphoid leukemia. Generally, the molecular mechanisms underlying leukemic transformation of Philadelphia-negative myeloprolife... | Oral | DrugAdministrationRoute | CC BY | 34022887 | 19,397,359 | 2021-05-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arteriospasm coronary'. | Re-Irradiation in Patients with Recurrent Rectal Cancer is Safe and Feasible.
BACKGROUND
There is no consensus yet for the best treatment regimen in patients with recurrent rectal cancer (RRC). This study aims to evaluate toxicity and oncological outcomes after re-irradiation in patients with RRC in our center. Clinica... | CAPECITABINE | DrugsGivenReaction | CC BY | 34023946 | 20,006,970 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiotoxicity'. | Re-Irradiation in Patients with Recurrent Rectal Cancer is Safe and Feasible.
BACKGROUND
There is no consensus yet for the best treatment regimen in patients with recurrent rectal cancer (RRC). This study aims to evaluate toxicity and oncological outcomes after re-irradiation in patients with RRC in our center. Clinica... | CAPECITABINE | DrugsGivenReaction | CC BY | 34023946 | 20,006,970 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Re-Irradiation in Patients with Recurrent Rectal Cancer is Safe and Feasible.
BACKGROUND
There is no consensus yet for the best treatment regimen in patients with recurrent rectal cancer (RRC). This study aims to evaluate toxicity and oncological outcomes after re-irradiation in patients with RRC in our center. Clinica... | CAPECITABINE | DrugsGivenReaction | CC BY | 34023946 | 20,006,970 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal toxicity'. | Re-Irradiation in Patients with Recurrent Rectal Cancer is Safe and Feasible.
BACKGROUND
There is no consensus yet for the best treatment regimen in patients with recurrent rectal cancer (RRC). This study aims to evaluate toxicity and oncological outcomes after re-irradiation in patients with RRC in our center. Clinica... | CAPECITABINE | DrugsGivenReaction | CC BY | 34023946 | 20,006,970 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematotoxicity'. | Re-Irradiation in Patients with Recurrent Rectal Cancer is Safe and Feasible.
BACKGROUND
There is no consensus yet for the best treatment regimen in patients with recurrent rectal cancer (RRC). This study aims to evaluate toxicity and oncological outcomes after re-irradiation in patients with RRC in our center. Clinica... | CAPECITABINE | DrugsGivenReaction | CC BY | 34023946 | 20,006,970 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neurotoxicity'. | Re-Irradiation in Patients with Recurrent Rectal Cancer is Safe and Feasible.
BACKGROUND
There is no consensus yet for the best treatment regimen in patients with recurrent rectal cancer (RRC). This study aims to evaluate toxicity and oncological outcomes after re-irradiation in patients with RRC in our center. Clinica... | CAPECITABINE | DrugsGivenReaction | CC BY | 34023946 | 20,006,970 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin toxicity'. | Re-Irradiation in Patients with Recurrent Rectal Cancer is Safe and Feasible.
BACKGROUND
There is no consensus yet for the best treatment regimen in patients with recurrent rectal cancer (RRC). This study aims to evaluate toxicity and oncological outcomes after re-irradiation in patients with RRC in our center. Clinica... | CAPECITABINE | DrugsGivenReaction | CC BY | 34023946 | 20,006,970 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Re-Irradiation in Patients with Recurrent Rectal Cancer is Safe and Feasible.
BACKGROUND
There is no consensus yet for the best treatment regimen in patients with recurrent rectal cancer (RRC). This study aims to evaluate toxicity and oncological outcomes after re-irradiation in patients with RRC in our center. Clinica... | CAPECITABINE | DrugsGivenReaction | CC BY | 34023946 | 20,006,970 | 2021-09 |
What was the administration route of drug 'CAPECITABINE'? | Re-Irradiation in Patients with Recurrent Rectal Cancer is Safe and Feasible.
BACKGROUND
There is no consensus yet for the best treatment regimen in patients with recurrent rectal cancer (RRC). This study aims to evaluate toxicity and oncological outcomes after re-irradiation in patients with RRC in our center. Clinica... | Oral | DrugAdministrationRoute | CC BY | 34023946 | 20,006,970 | 2021-09 |
What was the dosage of drug 'CAPECITABINE'? | Re-Irradiation in Patients with Recurrent Rectal Cancer is Safe and Feasible.
BACKGROUND
There is no consensus yet for the best treatment regimen in patients with recurrent rectal cancer (RRC). This study aims to evaluate toxicity and oncological outcomes after re-irradiation in patients with RRC in our center. Clinica... | 825 MG/ M2 TWICE DAILY (ON WORKING DAYS). | DrugDosageText | CC BY | 34023946 | 19,405,591 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aortic thrombosis'. | Acute Brachial Arterial Embolic Occlusion Following Anticoagulant Discontinuation in a Renal Biopsy of a Nephrotic Syndrome Patient.
A 73-year-old woman with atrial fibrillation treated with rivaroxaban was hospitalized for nephrotic syndrome. After discontinuation of rivaroxaban to lower the risk of hemorrhagic events... | CARBAZOCHROME SODIUM SULFONATE, PREDNISOLONE, RIVAROXABAN | DrugsGivenReaction | CC BY-NC-ND | 34024856 | 20,191,090 | 2021-11-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Withdrawal syndrome'. | Acute Brachial Arterial Embolic Occlusion Following Anticoagulant Discontinuation in a Renal Biopsy of a Nephrotic Syndrome Patient.
A 73-year-old woman with atrial fibrillation treated with rivaroxaban was hospitalized for nephrotic syndrome. After discontinuation of rivaroxaban to lower the risk of hemorrhagic events... | PREDNISOLONE, RIVAROXABAN | DrugsGivenReaction | CC BY-NC-ND | 34024856 | 20,223,914 | 2021-11-01 |
What was the administration route of drug 'PREDNISOLONE'? | Acute Brachial Arterial Embolic Occlusion Following Anticoagulant Discontinuation in a Renal Biopsy of a Nephrotic Syndrome Patient.
A 73-year-old woman with atrial fibrillation treated with rivaroxaban was hospitalized for nephrotic syndrome. After discontinuation of rivaroxaban to lower the risk of hemorrhagic events... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34024856 | 20,223,914 | 2021-11-01 |
What was the outcome of reaction 'Aortic thrombosis'? | Acute Brachial Arterial Embolic Occlusion Following Anticoagulant Discontinuation in a Renal Biopsy of a Nephrotic Syndrome Patient.
A 73-year-old woman with atrial fibrillation treated with rivaroxaban was hospitalized for nephrotic syndrome. After discontinuation of rivaroxaban to lower the risk of hemorrhagic events... | Not recovered | ReactionOutcome | CC BY-NC-ND | 34024856 | 20,191,090 | 2021-11-01 |
What was the outcome of reaction 'Withdrawal syndrome'? | Acute Brachial Arterial Embolic Occlusion Following Anticoagulant Discontinuation in a Renal Biopsy of a Nephrotic Syndrome Patient.
A 73-year-old woman with atrial fibrillation treated with rivaroxaban was hospitalized for nephrotic syndrome. After discontinuation of rivaroxaban to lower the risk of hemorrhagic events... | Recovering | ReactionOutcome | CC BY-NC-ND | 34024856 | 20,223,914 | 2021-11-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Listeria monocytogenes Bacteremia During Isatuximab Therapy in a Patient with Multiple Myeloma.
An elderly patient with multiple myeloma (MM) was being treated with several regimens and developed a severe drug eruption, necessitating the use of atovaquone instead of trimethoprim-sulfamethoxazole for pneumocystis pneumo... | BORTEZOMIB, CARFILZOMIB, DARATUMUMAB, DEXAMETHASONE, ELOTUZUMAB, IXAZOMIB, LENALIDOMIDE, POMALIDOMIDE, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY-NC-ND | 34024861 | 19,468,075 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash'. | Listeria monocytogenes Bacteremia During Isatuximab Therapy in a Patient with Multiple Myeloma.
An elderly patient with multiple myeloma (MM) was being treated with several regimens and developed a severe drug eruption, necessitating the use of atovaquone instead of trimethoprim-sulfamethoxazole for pneumocystis pneumo... | ATOVAQUONE, BORTEZOMIB, CARFILZOMIB, DARATUMUMAB, DEXAMETHASONE SODIUM PHOSPHATE, ELOTUZUMAB, ISATUXIMAB, IXAZOMIB, LENALIDOMIDE, PENTAMIDINE, POMALIDOMIDE, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY-NC-ND | 34024861 | 20,647,802 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Listeria monocytogenes Bacteremia During Isatuximab Therapy in a Patient with Multiple Myeloma.
An elderly patient with multiple myeloma (MM) was being treated with several regimens and developed a severe drug eruption, necessitating the use of atovaquone instead of trimethoprim-sulfamethoxazole for pneumocystis pneumo... | BORTEZOMIB, CARFILZOMIB, DARATUMUMAB, DEXAMETHASONE, ELOTUZUMAB, IXAZOMIB, LENALIDOMIDE, POMALIDOMIDE, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY-NC-ND | 34024861 | 19,468,075 | 2021-11-15 |
What was the dosage of drug 'DEXAMETHASONE SODIUM PHOSPHATE'? | Listeria monocytogenes Bacteremia During Isatuximab Therapy in a Patient with Multiple Myeloma.
An elderly patient with multiple myeloma (MM) was being treated with several regimens and developed a severe drug eruption, necessitating the use of atovaquone instead of trimethoprim-sulfamethoxazole for pneumocystis pneumo... | 40 MG ON DAYS 1, 8, 15, AND 22 | DrugDosageText | CC BY-NC-ND | 34024861 | 20,647,802 | 2021-11-15 |
What was the dosage of drug 'ISATUXIMAB'? | Listeria monocytogenes Bacteremia During Isatuximab Therapy in a Patient with Multiple Myeloma.
An elderly patient with multiple myeloma (MM) was being treated with several regimens and developed a severe drug eruption, necessitating the use of atovaquone instead of trimethoprim-sulfamethoxazole for pneumocystis pneumo... | DAYS 1, 8, 15, AND 22 | DrugDosageText | CC BY-NC-ND | 34024861 | 20,647,802 | 2021-11-15 |
What was the outcome of reaction 'Bacteraemia'? | Listeria monocytogenes Bacteremia During Isatuximab Therapy in a Patient with Multiple Myeloma.
An elderly patient with multiple myeloma (MM) was being treated with several regimens and developed a severe drug eruption, necessitating the use of atovaquone instead of trimethoprim-sulfamethoxazole for pneumocystis pneumo... | Recovered | ReactionOutcome | CC BY-NC-ND | 34024861 | 19,439,256 | 2021-11-15 |
What was the outcome of reaction 'Listeriosis'? | Listeria monocytogenes Bacteremia During Isatuximab Therapy in a Patient with Multiple Myeloma.
An elderly patient with multiple myeloma (MM) was being treated with several regimens and developed a severe drug eruption, necessitating the use of atovaquone instead of trimethoprim-sulfamethoxazole for pneumocystis pneumo... | Recovered | ReactionOutcome | CC BY-NC-ND | 34024861 | 19,439,256 | 2021-11-15 |
What was the outcome of reaction 'Rash'? | Listeria monocytogenes Bacteremia During Isatuximab Therapy in a Patient with Multiple Myeloma.
An elderly patient with multiple myeloma (MM) was being treated with several regimens and developed a severe drug eruption, necessitating the use of atovaquone instead of trimethoprim-sulfamethoxazole for pneumocystis pneumo... | Recovered | ReactionOutcome | CC BY-NC-ND | 34024861 | 20,647,802 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dizziness'. | CYP2D6 in the Brain: Potential Impact on Adverse Drug Reactions in the Central Nervous System-Results From the ADRED Study.
Cytochrome P450 (CYP) 2D6 is a polymorphic enzyme expressed in the central nervous system (CNS), important in drug metabolism and with a potentially constitutive role in CNS function such as vigil... | LEVETIRACETAM | DrugsGivenReaction | CC BY | 34025403 | 20,104,555 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Headache'. | CYP2D6 in the Brain: Potential Impact on Adverse Drug Reactions in the Central Nervous System-Results From the ADRED Study.
Cytochrome P450 (CYP) 2D6 is a polymorphic enzyme expressed in the central nervous system (CNS), important in drug metabolism and with a potentially constitutive role in CNS function such as vigil... | LEVETIRACETAM | DrugsGivenReaction | CC BY | 34025403 | 20,104,555 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Syncope'. | CYP2D6 in the Brain: Potential Impact on Adverse Drug Reactions in the Central Nervous System-Results From the ADRED Study.
Cytochrome P450 (CYP) 2D6 is a polymorphic enzyme expressed in the central nervous system (CNS), important in drug metabolism and with a potentially constitutive role in CNS function such as vigil... | LEVETIRACETAM | DrugsGivenReaction | CC BY | 34025403 | 20,104,555 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'No adverse event'. | Eculizumab in the Treatment of Aquaporin-4 Seronegative Neuromyelitis Optica Spectrum Disorder: A Case Report.
Objective: To report the case of a 35-year-old woman with treatment-resistant aquaporin-4 (AQP-4) immunoglobulin G (IgG) seronegative neuromyelitis optica spectrum disorder (NMOSD) successfully treated with ec... | METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISONE, RITUXIMAB | DrugsGivenReaction | CC BY | 34025563 | 20,316,300 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Eculizumab in the Treatment of Aquaporin-4 Seronegative Neuromyelitis Optica Spectrum Disorder: A Case Report.
Objective: To report the case of a 35-year-old woman with treatment-resistant aquaporin-4 (AQP-4) immunoglobulin G (IgG) seronegative neuromyelitis optica spectrum disorder (NMOSD) successfully treated with ec... | METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISONE, RITUXIMAB | DrugsGivenReaction | CC BY | 34025563 | 20,316,300 | 2021 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Eculizumab in the Treatment of Aquaporin-4 Seronegative Neuromyelitis Optica Spectrum Disorder: A Case Report.
Objective: To report the case of a 35-year-old woman with treatment-resistant aquaporin-4 (AQP-4) immunoglobulin G (IgG) seronegative neuromyelitis optica spectrum disorder (NMOSD) successfully treated with ec... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34025563 | 20,316,300 | 2021 |
What was the administration route of drug 'PREDNISONE'? | Eculizumab in the Treatment of Aquaporin-4 Seronegative Neuromyelitis Optica Spectrum Disorder: A Case Report.
Objective: To report the case of a 35-year-old woman with treatment-resistant aquaporin-4 (AQP-4) immunoglobulin G (IgG) seronegative neuromyelitis optica spectrum disorder (NMOSD) successfully treated with ec... | Oral | DrugAdministrationRoute | CC BY | 34025563 | 20,316,300 | 2021 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Eculizumab in the Treatment of Aquaporin-4 Seronegative Neuromyelitis Optica Spectrum Disorder: A Case Report.
Objective: To report the case of a 35-year-old woman with treatment-resistant aquaporin-4 (AQP-4) immunoglobulin G (IgG) seronegative neuromyelitis optica spectrum disorder (NMOSD) successfully treated with ec... | FOR 5 DAYS FOR RELAPSES | DrugDosageText | CC BY | 34025563 | 20,316,300 | 2021 |
What was the dosage of drug 'PREDNISONE'? | Eculizumab in the Treatment of Aquaporin-4 Seronegative Neuromyelitis Optica Spectrum Disorder: A Case Report.
Objective: To report the case of a 35-year-old woman with treatment-resistant aquaporin-4 (AQP-4) immunoglobulin G (IgG) seronegative neuromyelitis optica spectrum disorder (NMOSD) successfully treated with ec... | REDUCED DOSE | DrugDosageText | CC BY | 34025563 | 20,316,300 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use issue'. | Myocarditis following COVID-19 vaccination.
The coronavirus disease 2019 (COVID-19) vaccination frequently leads to minor side-effects, that may be more intense after the second dose, but more serious side effects have been reported. We report a case of a 24-year-old man who presented to the hospital with acute subster... | COLCHICINE, LOSARTAN POTASSIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METOPROLOL SUCCINATE, TOZINAMERAN | DrugsGivenReaction | CC BY-NC-ND | 34025885 | 20,449,534 | 2021-08 |
What was the administration route of drug 'LOSARTAN POTASSIUM'? | Myocarditis following COVID-19 vaccination.
The coronavirus disease 2019 (COVID-19) vaccination frequently leads to minor side-effects, that may be more intense after the second dose, but more serious side effects have been reported. We report a case of a 24-year-old man who presented to the hospital with acute subster... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34025885 | 20,449,534 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Onset of Addison Disease appeared during the first trimester of a twin pregnancy: A case report.
Addison Disease is an uncommon, life-threatening condition affecting people at any age, including women during pregnancy. If left untreated, the disease can be rapidly fatal, but the prognosis is good if promptly recognized... | BETAMETHASONE, FLUDROCORTISONE, HYDROCORTISONE, HYDROXYPROGESTERONE CAPROATE, PROGESTERONE | DrugsGivenReaction | CC BY | 34026120 | 20,226,897 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal exposure during pregnancy'. | Onset of Addison Disease appeared during the first trimester of a twin pregnancy: A case report.
Addison Disease is an uncommon, life-threatening condition affecting people at any age, including women during pregnancy. If left untreated, the disease can be rapidly fatal, but the prognosis is good if promptly recognized... | BETAMETHASONE, FLUDROCORTISONE, HYDROCORTISONE, HYDROXYPROGESTERONE CAPROATE, PROGESTERONE | DrugsGivenReaction | CC BY | 34026120 | 20,291,192 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastroenteritis viral'. | Onset of Addison Disease appeared during the first trimester of a twin pregnancy: A case report.
Addison Disease is an uncommon, life-threatening condition affecting people at any age, including women during pregnancy. If left untreated, the disease can be rapidly fatal, but the prognosis is good if promptly recognized... | BETAMETHASONE, FLUDROCORTISONE, HYDROCORTISONE, HYDROXYPROGESTERONE CAPROATE, PROGESTERONE | DrugsGivenReaction | CC BY | 34026120 | 20,226,897 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperglycaemia'. | Onset of Addison Disease appeared during the first trimester of a twin pregnancy: A case report.
Addison Disease is an uncommon, life-threatening condition affecting people at any age, including women during pregnancy. If left untreated, the disease can be rapidly fatal, but the prognosis is good if promptly recognized... | BETAMETHASONE, FLUDROCORTISONE, HYDROCORTISONE, HYDROXYPROGESTERONE CAPROATE, PROGESTERONE | DrugsGivenReaction | CC BY | 34026120 | 20,226,897 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Low birth weight baby'. | Onset of Addison Disease appeared during the first trimester of a twin pregnancy: A case report.
Addison Disease is an uncommon, life-threatening condition affecting people at any age, including women during pregnancy. If left untreated, the disease can be rapidly fatal, but the prognosis is good if promptly recognized... | BETAMETHASONE, FLUDROCORTISONE, HYDROCORTISONE, HYDROXYPROGESTERONE CAPROATE, PROGESTERONE | DrugsGivenReaction | CC BY | 34026120 | 20,291,192 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature baby'. | Onset of Addison Disease appeared during the first trimester of a twin pregnancy: A case report.
Addison Disease is an uncommon, life-threatening condition affecting people at any age, including women during pregnancy. If left untreated, the disease can be rapidly fatal, but the prognosis is good if promptly recognized... | BETAMETHASONE, FLUDROCORTISONE, HYDROCORTISONE, HYDROXYPROGESTERONE CAPROATE, PROGESTERONE | DrugsGivenReaction | CC BY | 34026120 | 20,291,192 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature delivery'. | Onset of Addison Disease appeared during the first trimester of a twin pregnancy: A case report.
Addison Disease is an uncommon, life-threatening condition affecting people at any age, including women during pregnancy. If left untreated, the disease can be rapidly fatal, but the prognosis is good if promptly recognized... | BETAMETHASONE, FLUDROCORTISONE, HYDROCORTISONE, HYDROXYPROGESTERONE CAPROATE, PROGESTERONE | DrugsGivenReaction | CC BY | 34026120 | 20,226,897 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature rupture of membranes'. | Onset of Addison Disease appeared during the first trimester of a twin pregnancy: A case report.
Addison Disease is an uncommon, life-threatening condition affecting people at any age, including women during pregnancy. If left untreated, the disease can be rapidly fatal, but the prognosis is good if promptly recognized... | BETAMETHASONE, FLUDROCORTISONE, HYDROCORTISONE, HYDROXYPROGESTERONE CAPROATE, PROGESTERONE | DrugsGivenReaction | CC BY | 34026120 | 20,226,897 | 2021-05 |
What was the administration route of drug 'PROGESTERONE'? | Onset of Addison Disease appeared during the first trimester of a twin pregnancy: A case report.
Addison Disease is an uncommon, life-threatening condition affecting people at any age, including women during pregnancy. If left untreated, the disease can be rapidly fatal, but the prognosis is good if promptly recognized... | Transplacental | DrugAdministrationRoute | CC BY | 34026120 | 20,291,192 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asthenia'. | Statin-associated necrotizing autoimmune myopathy with concurrent myasthenia gravis.
Statin treatment has been associated with necrotizing autoimmune myopathy and has been linked to myasthenia gravis. We present an unprecedented clinical challenge with both disorders occurring in a patient treated with statins few mont... | ASPIRIN, ATORVASTATIN, BISOPROLOL, EZETIMIBE\SIMVASTATIN, RAMIPRIL, TICAGRELOR | DrugsGivenReaction | CC BY-NC-ND | 34026125 | 19,510,894 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood creatine phosphokinase increased'. | Statin-associated necrotizing autoimmune myopathy with concurrent myasthenia gravis.
Statin treatment has been associated with necrotizing autoimmune myopathy and has been linked to myasthenia gravis. We present an unprecedented clinical challenge with both disorders occurring in a patient treated with statins few mont... | ASPIRIN, ATORVASTATIN, BISOPROLOL, EZETIMIBE\SIMVASTATIN, RAMIPRIL, TICAGRELOR | DrugsGivenReaction | CC BY-NC-ND | 34026125 | 19,510,894 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Statin-associated necrotizing autoimmune myopathy with concurrent myasthenia gravis.
Statin treatment has been associated with necrotizing autoimmune myopathy and has been linked to myasthenia gravis. We present an unprecedented clinical challenge with both disorders occurring in a patient treated with statins few mont... | ASPIRIN, ATORVASTATIN, BISOPROLOL, EZETIMIBE\SIMVASTATIN, RAMIPRIL, TICAGRELOR | DrugsGivenReaction | CC BY-NC-ND | 34026125 | 19,510,894 | 2021-05 |
What was the dosage of drug 'EZETIMIBE\ROSUVASTATIN'? | Statin-associated necrotizing autoimmune myopathy with concurrent myasthenia gravis.
Statin treatment has been associated with necrotizing autoimmune myopathy and has been linked to myasthenia gravis. We present an unprecedented clinical challenge with both disorders occurring in a patient treated with statins few mont... | EZETIMIBE 10MG, ROSUVASTATIN 20MG | DrugDosageText | CC BY-NC-ND | 34026125 | 19,496,474 | 2021-05 |
What was the dosage of drug 'EZETIMIBE\SIMVASTATIN'? | Statin-associated necrotizing autoimmune myopathy with concurrent myasthenia gravis.
Statin treatment has been associated with necrotizing autoimmune myopathy and has been linked to myasthenia gravis. We present an unprecedented clinical challenge with both disorders occurring in a patient treated with statins few mont... | 10MG/20MG, UNK | DrugDosageText | CC BY-NC-ND | 34026125 | 19,510,894 | 2021-05 |
What was the outcome of reaction 'Asthenia'? | Statin-associated necrotizing autoimmune myopathy with concurrent myasthenia gravis.
Statin treatment has been associated with necrotizing autoimmune myopathy and has been linked to myasthenia gravis. We present an unprecedented clinical challenge with both disorders occurring in a patient treated with statins few mont... | Recovering | ReactionOutcome | CC BY-NC-ND | 34026125 | 19,510,894 | 2021-05 |
What was the outcome of reaction 'Blood creatine phosphokinase increased'? | Statin-associated necrotizing autoimmune myopathy with concurrent myasthenia gravis.
Statin treatment has been associated with necrotizing autoimmune myopathy and has been linked to myasthenia gravis. We present an unprecedented clinical challenge with both disorders occurring in a patient treated with statins few mont... | Recovering | ReactionOutcome | CC BY-NC-ND | 34026125 | 19,510,894 | 2021-05 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.